Acute and Long-Term Effects of Insparin and Pioglitazone on Tissue Distribution of Glucose Uptake

Acute and Long-Term Effects of Insparin and Pioglitazone on Tissue Distribution of Glucose Uptake

Saved in:

Bibliographic Details
Main Authors:	Sara Ranjbar, Vijay Hegde, Nikhil V Dhurandhar
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Current Developments in Nutrition
Online Access:	http://www.sciencedirect.com/science/article/pii/S247529912502075X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A 70 Amino Acid Fragment of Insparin Retains Its Potential to Upregulate Distal Insulin Signaling
by: Tanvi Kale, et al.
Published: (2025-05-01)

Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
by: Eric M Blalock, et al.
Published: (2010-04-01)

Effect of Pioglitazone on the Fructose-Induced Abdominal Adipose Tissue Dysfunction
by: Ana Alzamendi, et al.
Published: (2012-01-01)

E4orf1 Enhances Glycemic Regulation, Cognitive Function, and Obesity-Linked Molecular Pathways in a Male Mouse Model of Obesity-Associated Alzheimer’s Disease
by: Vijay Hegde, et al.
Published: (2025-05-01)

Influence of Acute and Chronic Exercise on Glucose Uptake
by: Martin Röhling, et al.
Published: (2016-01-01)

P-96 LONG-TERM PIOGLITAZONE TREATMENT AND LIVER STIFFNESS IN MASLD PATIENTS: INSIGHTS FROM A MULTICENTRIC STUDY
by: Mario Guimarães Pessoa, et al.
Published: (2024-12-01)

Comparative Analysis of Pioglitazone and Tirzepatide on Body Weight, Glucose Levels, Neuroinflammation, and Oxidative Stress in Diabetic Rats
by: Alhowail A, et al.
Published: (2025-07-01)

Pharmacokinetic Interaction of Favipiravir with Citalopram and Pioglitazone
by: Zeliha Keskin Alkaç, et al.
Published: (2022-12-01)

Therapeutic Potential and Challenges of Pioglitazone in Cancer Treatment
by: Maria Vasileiou, et al.
Published: (2025-02-01)

Effect of Pioglitazone on Endoplasmic Reticulum Stress and Autophagy Response in the Perivascular Adipose Tissue of Type 2 Diabetic Rats
by: Erkan Civelek, et al.
Published: (2025-01-01)

Antidiabetic E4orf1 protein prevents hepatic steatosis and reduces markers of aging-related cellular damage in high fat fed older mice
by: Zahra Mostofinejad, et al.
Published: (2021-03-01)

Genkwanin glycosides are major active compounds in Phaleria nisidai extract mediating improved glucose homeostasis by stimulating glucose uptake into adipose tissues
by: Carla Horvath, et al.
Published: (2025-08-01)

Long-term results of transferring the patient from therapy with glucagon-like peptide-1 receptor agonists in combination with metformin to a dipeptidyl peptidase-4 inhibitor in combination with pioglitazone and inhibitor of type 2 sodium-glucose cotransporter in type 2 diabetes
by: V. V. Salukhov, et al.
Published: (2024-03-01)

Pioglitazone Upregulates Angiotensin Converting Enzyme 2 Expression in Insulin-Sensitive Tissues in Rats with High-Fat Diet-Induced Nonalcoholic Steatohepatitis
by: Wei Zhang, et al.
Published: (2014-01-01)

APPLICATION OF PIOGLITAZONE IN THE COMPREHENSIVE TREATMENT OF PSORIATIC PATIENTS WITH CONCOMITANT ALIMENTARY OBESITY
by: Ya.O. Yemchenko, et al.
Published: (2020-12-01)

Simultaneous stability-indicating analysis of nateglinide and pioglitazone using RP-HPLC
by: Sriparni Das, et al.
Published: (2025-12-01)

Long-term spatial patterns in COVID-19 booster vaccine uptake
by: Anthony J. Wood, et al.
Published: (2025-07-01)

Safety Assessment of a Potential Anti-diabetic Agent in a Pre-clinical Model
by: Md Abu Bakkar Siddik, et al.
Published: (2025-05-01)

The Effects of Pioglitazone on Biochemical Markers of Bone Turnover in the Patients with Type 2 Diabetes
by: Wen-hua Xiao, et al.
Published: (2013-01-01)

Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease
by: Bonnie L. Blazer-Yost, et al.
Published: (2010-01-01)

Economic effectiveness of fixed-dose combination of alogliptin and pioglitazone in diabetes mellitus treatment
by: S. К. Zyryanov, et al.
Published: (2025-02-01)

Combination of dapagliflozin and pioglitazone lacks superiority against monotherapy in streptozotocin-induced nephropathy
by: Aneta Cinakova, et al.
Published: (2025-01-01)

Glucose measurements in sheep using a long-term continuous glucose monitor designed for humans
by: Barbara Roqueto dos Reis, et al.
Published: (2024-11-01)

Association between the triglyceride glucose index and long-term outcomes in patients with acute coronary syndrome and chronic kidney disease
by: Feng Wang, et al.
Published: (2025-06-01)

Diet Modifies Pioglitazone’s Influence on Hepatic PPARγ-Regulated Mitochondrial Gene Expression
by: Sakil Kulkarni, et al.
Published: (2020-01-01)

Pentylenetetrazol-induced seizures and brain neuroinflammation markers under conditions of pitolisant and pioglitazone use
by: O. Yehorenko, et al.
Published: (2025-04-01)

Enhanced transdermal delivery of pioglitazone hydrochloride via conductive hydrogel microneedles combined with iontophoresis
by: Jianling Hu, et al.
Published: (2025-06-01)

Gender-Specific Variations in Fat-Free Mass Preservation and Resting Metabolic Rate Adaptations After Weight Loss
by: Gaurav Mahendra Kudchadkar, et al.
Published: (2025-05-01)

Development and validation of analytical procedure for analysis of polyvinylpyrrolidone in tablets containing metformin hydrochloride and pioglitazone hydrochloride
by: Sri Paryanti, et al.
Published: (2025-05-01)

Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis.
by: Christine Clar, et al.
Published: (2009-07-01)

Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?
by: Chiara Cilibrasi, et al.
Published: (2016-01-01)

Possibilities of application a fixed combination of alogliptin and pioglitazone for type 2 diabetes mellitus treatment
by: M. V. Shestakova, et al.
Published: (2021-07-01)

Zataria multiflora and Pioglitazone Affect Systemic Inflammation and Oxidative Stress Induced by Inhaled Paraquat in Rats
by: Fatemeh Amin, et al.
Published: (2021-01-01)

Development and Characterization of a Nanocomposed Pioglitazone Hydrochloride-Loaded Niosomal Suspension for Targeted Drug Delivery
by: Shweta Kyadalwar, et al.
Published: (2025-01-01)

Is long-bout sedentary behaviour associated with long-term glucose levels 3 months after acute ischaemic stroke? A prospective observational cohort study
by: Coralie English, et al.
Published: (2020-11-01)

Oral glucose-lowering drugs and long-term risk of benign prostatic hyperplasia
by: Stanislav N. Volkov, et al.
Published: (2024-01-01)

Quantification of the relation between continuous glucose monitoring observation period and the estimation error in assessing long-term glucose regulation
by: Gozewijn D Laverman, et al.
Published: (2025-02-01)

Predicting the long-term viscoelastic response by short-term tests in polymers
by: Reza Afshar, et al.
Published: (2025-07-01)

Mapping of the Glucose Metabolism Heterogeneity in Atherosclerosis: Correlation With 2-Deoxyglucose Uptake
by: Joseph Haddad MD, et al.
Published: (2024-09-01)

Core–shell nanofibers for localized melanoma therapy delivering Pioglitazone nanoemulsions and gemcitabine dual loaded system
by: Azam Jafari-Najaf-Abadi, et al.
Published: (2025-08-01)